INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$2.00 USD
-0.02 (-0.99%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $1.98 -0.02 (-1.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Intelligent Bio Solutions Inc falls in the month of June.
All items in Millions except Per Share data.
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 2 | 8 | 13 | 0 |
Receivables | NA | 1 | 2 | 3 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1 | 0 | 0 | 0 |
Other Current Assets | NA | 1 | 1 | 3 | 2 |
Total Current Assets | NA | 4 | 11 | 18 | 2 |
Net Property & Equipment | NA | 1 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 5 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 1 | 4 | 0 |
Total Assets | NA | 10 | 12 | 22 | 2 |
Liabilities & Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 5 |
Accounts Payable | NA | 3 | 2 | 2 | 1 |
Current Portion Long-Term Debt | NA | 2 | 3 | 2 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 2 |
Total Current Liabilities | NA | 6 | 5 | 4 | 8 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 1 | 3 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 7 | 6 | 7 | 8 |
Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 46 | 38 | 38 | 11 |
Retained Earnings | NA | -42 | -31 | -23 | -16 |
Other Equity | NA | -1 | -1 | -1 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 4 | 7 | 15 | -5 |
Total Liabilities & Shareholder's Equity | NA | 10 | 12 | 22 | 2 |
Total Common Equity | 0 | 4 | 7 | 15 | -5 |
Shares Outstanding | 3.10 | 0.10 | 0.00 | 0.00 | 0.00 |
Book Value Per Share | 0.00 | 36.90 | 6.55 | 15.00 | -5.24 |
Fiscal Year End for Intelligent Bio Solutions Inc falls in the month of June.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 9 | 1 | 0 | 2 |
Receivables | NA | 1 | 1 | 1 | 1 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1 | 1 | 1 | 1 |
Other Current Assets | NA | 0 | 0 | 0 | 1 |
Total Current Assets | NA | 12 | 3 | 3 | 4 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 5 | 5 | 5 | 5 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 17 | 9 | 9 | 10 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 2 | 4 | 3 |
Current Portion Long-Term Debt | NA | 2 | 2 | 2 | 2 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 0 | 0 | 0 |
Total Current Liabilities | NA | 6 | 5 | 7 | 6 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 6 | 6 | 7 | 7 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 61 | 50 | 46 | 46 |
Retained Earnings | NA | -49 | -46 | -44 | -42 |
Other Equity | NA | -1 | -1 | -1 | -1 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 11 | 3 | 1 | 4 |
Total Liabilities & Shareholder's Equity | NA | 17 | 9 | 9 | 10 |
Total Common Equity | 0 | 11 | 3 | 1 | 4 |
Shares Outstanding | 3.10 | 2.80 | 1.40 | 0.10 | 0.10 |
Book Value Per Share | 0.00 | 3.93 | 2.25 | 12.40 | 36.90 |